Sarcoidosis of the upper and lower airways

Adam S. Morgenthau, Alvin S. Teirstein

Research output: Contribution to journalReview articlepeer-review

16 Scopus citations


Sarcoidosis is a systemic granulomatous disease of undetermined etiology characterized by a variable clinical presentation and disease course. Although clinical granulomatous inflammation may occur within any organ system, more than 90% of sarcoidosis patients have lung disease. Sarcoidosis is considered an interstitial lung disease that is frequently characterized by restrictive physiologic dysfunction on pulmonary function tests. However, sarcoidosis also involves the airways (large and small), causing obstructive airways disease. It is one of a few interstitial lung diseases that affects the entire length of the respiratory tract - from the nose to the terminal bronchioles - and causes a broad spectrum of airways dysfunction. This article examines airway dysfunction in sarcoidosis. The anatomical structure of the airways is the organizational framework for our discussion. We discuss sarcoidosis involving the nose, sinuses, nasal passages, larynx, trachea, bronchi and small airways. Common complications of airways disease, such as, atelectasis, fibrosis, bullous leions, bronchiectasis, cavitary lesions and mycetomas, are also reviewed.

Original languageEnglish
Pages (from-to)823-833
Number of pages11
JournalExpert Review of Respiratory Medicine
Issue number6
StatePublished - Dec 2011
Externally publishedYes


  • Airways dysfunction
  • Laryngeal sarcoidosis
  • Mycetoma
  • Pulmonary sarcoidosis
  • Sinonasal sarcoidsois


Dive into the research topics of 'Sarcoidosis of the upper and lower airways'. Together they form a unique fingerprint.

Cite this